TotalMarketCap

PRF Technologies

PRFXNasdaq IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.643 M

$0.76 -1.27%

Close of 6 Nov 2026

As of 6 Nov 2026, PRF Technologies (PRFX) has a market capitalization of $2.64M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$17.0K

#3600 by revenue

Earnings

-$5.02M

Loss-making

Shares outstanding

830,613

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #475NeuroSense TherapeuticsNRSN$2.75M
  2. #476Decoy TherapeuticsDCOY$2.70M
  3. #477PRF TechnologiesPRFX$2.64M
  4. #478Silo PharmaSILO$2.57M
  5. #479Galmed PharmaceuticalsEOCN$2.55M

What if PRF Technologies were worth as much as…

Open the what-if tool →

Gold $28.2T

$8,069,653

Per share 10,684,037× higher

Bitcoin $1.53T

$436,634.89

Per share 578,095× higher

Apple $5.02T

$1,433,432

Per share 1,897,831× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for PRF Technologies are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.